NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 10, 2026 Bullish $28.75 V 0
Jan 26, 2026 $33.03 +2.50% $31.73 X 95.92% 0
Jan 26, 2026 $32.72 +1.56% $31.73 X 96.87% 0
Jan 26, 2026 $180.00 +458.66% Unrealistic Excluded from avg $31.73 X 0.00% 0
Dec 4, 2025 $36.28 +2.44% $38.57 V 94.05% 1
Dec 4, 2025 $35.95 +1.53% $38.57 V 93.21% 1
Dec 4, 2025 $34.56 +2.01% $38.57 V 89.60% 1
Nov 24, 2025 $35.26 +2.93% $34.65 V 98.23% 1
Nov 24, 2025 $34.89 +1.83% $34.65 V 99.31% 4
Nov 24, 2025 Bullish $34.65 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE